You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
27 November 2019
Nestlé Health Science has entered into a strategic collaboration with Caelus Health for the development of microbiome-based food supplements.
26 November 2019
Nestlé has entered into a partnership with the University of California San Diego Center for Microbiome Innovation (CMI) as it seeks to develop the “next generation of health-promoting products”.
23 October 2019
Nestlé has established a group strategy and business development function to help “identify internal and external strategic growth opportunities”.
7 October 2019
Nestlé Skin Health has reverted to its original name of Galderma and gained a new team following the recent takeover by a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
4 October 2019
Nestlé has completed the sale of its Skin Health business for CHF10.2 billion (USD10.2 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
26 September 2019
Nestlé Health Science has taken a stake in Before Brands, Nature's Sunshine Products is entering the cannabidiol (CBD) market in the US, and Venture Life has released financial results.
24 September 2019
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two medicines containing benzoyl peroxide – Galderma's Acnecide Face Gel and Acnecide Face Wash – to be switched from pharmacy (P) to general-sale list (GSL) status.
26 August 2019
Nestlé Health Science is expanding into personalised nutrition by acquiring the vitamins, minerals and supplements (VMS) company Persona for an undisclosed sum.
29 July 2019
Nestlé highlighted "strong demand" for its recently-launched range of Dr. Formulated CBD products when it reported financial results for the first half of 2019.
16 May 2019
Nestlé has entered into exclusive negotiations on the sale of its Skin Health business for CHF10.2 billion (USD10.1 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).